Welcome to LookChem.com Sign In|Join Free
  • or
Boc-O-Bn-D-Ser-NH2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

74604-28-7

Post Buying Request

74604-28-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

74604-28-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 74604-28-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,6,0 and 4 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 74604-28:
(7*7)+(6*4)+(5*6)+(4*0)+(3*4)+(2*2)+(1*8)=127
127 % 10 = 7
So 74604-28-7 is a valid CAS Registry Number.

74604-28-7Upstream product

74604-28-7Relevant academic research and scientific papers

Amidation of carboxylic acids via the mixed carbonic carboxylic anhydrides and its application to synthesis of antidepressant (1S,2R)-tranylcypromine

Ezawa, Tetsuya,Kawashima, Yuya,Noguchi, Takuya,Jung, Seunghee,Imai, Nobuyuki

, p. 1690 - 1699 (2017)

Primary amidations of carboxylic acids 1 or 3 with NH4Cl in the presence of ClCO2Et and Et3N were developed to afford the corresponding primary amides in 22% to quantitative yields. Additionally, we have applied the amidation to the preparation of various amides containing hydroxamic acids and achieved the synthesis of (1S,2R)-tranylcypromine as an antidepressant medicine via Lossen rearrangement.

BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS

-

Page/Page column 60-91, (2012/05/20)

The present invention is directed to compounds of formula I and pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of Syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition Syk kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by Syk kinase activity, such as Non Hodgkin's Lymphoma.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 74604-28-7